Memory, Learning and Cognition
Cognition is the term used to define the process of thoughts, including memory, awareness, reasoning and perception. Cognitive enhancement describes the improvement of the information processing systems of the mind and the extension of its main capacities, which can be undertaken simply by learning, especially during early development.
Memory, Learning and Cognition Products Targets
- Voltage-gated Calcium Channel (CaV) (38)
- Others (13)
- D4 Receptor (12)
- 5-HT7 Receptor (11)
- 5-HT6 Receptor (14)
- 5-ht5 Receptor (2)
- 5-HT4 Receptor (17)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- Glutamate (Metabotropic) Group III Receptor (26)
- Glutamate (Metabotropic) Group II Receptor (33)
- Glutamate (Metabotropic) Group I Receptor (54)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- Protein Kinase C (29)
- Calmodulin-Dependent Kinase (8)
- D3 Receptor (12)
- NMDA Receptor (87)
- Kainate Receptor (22)
- D2 Receptor (14)
- D1 and D5 Receptor (16)
- Amyloid beta Peptide (28)
- Histamine H1 Receptor (17)
- M5 Receptor (2)
- M4 Receptor (3)
- M3 Receptor (4)
- M2 Receptor (5)
- M1 Receptor (8)
- Delta opioid receptor (16)
- Protein serine and threonine phosphatase (16)
- Histone Deacetylase (19)
- Phosphodiesterase (34)
Products for Memory, Learning and Cognition - Page 51
- Cat.No. Product Name Information/Activity
-
BCC6731
Salsolinol-1-carboxylic acid
57256-34-5
-
BCC6632
Spaglumic acid
Spaglumic Acid is a neuropeptide found in millimolar concentrations in brain.
-
BCN2571
L-Theanine
L-Theanine (L-Glutamic Acid γ-ethyl amide)is a non-protein amino acid contained in green tea leaves, which blocks the binding of L-glutamic acid to glutamate receptors in the brain, and with neuroprotective and anti-oxidative activities. L-Theanine causes anti-stress effects via the inhibition of cortical neuron excitation by oral intake.
-
BCC2512
Zonisamide
Zonisamide is a 1,2 benzisoxazole derivative and the first agent of this chemical class to be developed as an antiepileptic drug.
-
BCC6566
cis-ACPD
477331-06-9
-
BCC2894
H-D-Asp-OH
(-)-Aspartic acid is an endogenous NMDA receptor agonist.
-
BCC2881
H-Asp-OH
L-Aspartic acid is is an amino acid, shown to be a suitable prodrug for colon-specific drug deliverly.
-
BCC6571
L-Cysteinesulfinic acid
L-Cysteinesulfinic acid is a potent agonist at several rat metabotropic glutamate receptors (mGluRs) with pEC50s of 3.92±0.03, 4.6±0.2, 3.9±0.2, 2.7±0.2, 4.0±0.2, and 3.94±0.08 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectively.
-
BCC6013
GLYX 13
Rapastinel (GLYX-13) is an N-methyl-D-aspartate receptor (NMDAR) modulator that has characteristics of a glycine site partial agonist.
-
BCC6588
(R)-(+)-HA-966
(R)-(+)-HA-966 ((+)-HA-966) is a partial agonist/antagonist of glycine site of the N-methyl-D-aspartate (NMDA) receptor complex. (R)-(+)-HA-966 selectively blocks the activation of the mesolimbic dopamine system by amphetamine. (R)-(+)-HA-966 can cross the blood-brain barrier and has the potential for neuropathic and acute pain.


